Drug burden index and potentially inappropriate medications in community-dwelling older people: The impact of home medicines review

Drugs and Aging

Volumn 27, Issue 2, 2010, Pages 135-148

  Castelino, Ronald L ^a   Hilmer, Sarah N ^b,c   Bajorek, Beata V ^a,b   Nishtala, Prasad ^a   Chen, Timothy F ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Cholinergic receptor antagonists, therapeutic use; Community care; Elderly; Hypnosedatives, therapeutic use; Medication errors; Prescribing

Indexed keywords

AMITRIPTYLINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CODEINE; DIAZEPAM; OLANZAPINE; OXYBUTYNIN; PRAZOSIN; PROCHLORPERAZINE; SEDATIVE AGENT; SERTRALINE; TEMAZEPAM; TRAMADOL;

AGED; ARTICLE; COGNITION; COMMUNITY CARE; CRITERION VARIABLE; DRUG BURDEN INDEX; DRUG EXPOSURE; DRUG INDICATION; DRUG MONITORING; DRUG PROGRAM; DRUG USE; FEMALE; HEALTH SERVICE; HOME MEDICATION REVIEW; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION THERAPY MANAGEMENT; OUTCOME ASSESSMENT; PHARMACIST; PHYSICAL PERFORMANCE; POTENTIALLY INAPPROPRIATE MEDICATION; PRESCRIPTION; PRIORITY JOURNAL; SCORING SYSTEM;

AGED; DRUG INTERACTIONS; DRUG PRESCRIPTIONS; DRUG UTILIZATION; HOME CARE SERVICES; HOMES FOR THE AGED; HUMANS; MEDICATION ERRORS; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS;

EID: 77149121760     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.2165/11531560-000000000-00000     Document Type: Article

References (57)

1. Castelino RL, Bajorek BV, Chen TF. Targeting suboptimal prescribing in the elderly: a review of the impact of pharmacy services. Ann Pharmacother 2009; 43 (6): 1096-1106
2. Zermansky AG, Alldred DP, Petty DR, et al. Clinical medication review by a pharmacist of elderly people living in care homes: randomised controlled trial. Age Ageing 2006; 35 (6): 586-591
3. Goldberg RM, Mabee J, Chan L, et al. Drug-drug and drugdisease interactions in the ED: analysis of a high-risk population. Am J Emerg Med 1996; 14 (5): 447-450
4. Hilmer SN, Gnjidic D. The effects of polypharmacy in older adults. Clin Pharmacol Ther 2009; 85 (1): 86-88
5. Beyth RJ, Shorr RI. Principles of drug therapy in older patients: rational drug prescribing. Clin Geriatr Med 2002; 18 (3): 577-592
6. Beers MH, Ouslander JG, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing home residents: UCLA Division of Geriatric Medicine. Arch Intern Med 1991; 151 (9): 1825-1832
7. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly: an update. Arch Intern Med 1997; 157 (14): 1531-1536
8. Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003; 163 (22): 2716-2724
9. Zhan C, Sangl J, Bierman AS, et al. Potentially inappropriate medication use in the community-dwelling elderly: findings from the 1996 Medical Expenditure Panel Survey. JAMA 2001; 286 (2): 2823-2829
10. Page 2nd RL, Ruscin JM. The risk of adverse drug events and hospital-related morbidity and mortality among older adults with potentially inappropriate medication use. Am J Geriatr Pharmacother 2006; 4 (4): 297-305
11. Barry PJ, O'Keefe N, O'Connor KA, et al. Inappropriate prescribing in the elderly: a comparison of the Beers criteria and the improved prescribing in the elderly tool (IPET) in acutely ill elderly hospitalized patients. J Clin Pharm Ther 2006; 31 (6): 617-626
12. Basger BJ, Chen TF, Moles RJ. Inappropriate medication use and prescribing indicators in elderly Australians: development of a prescribing indicators tool. Drugs Aging 2008; 25 (9): 777-793
13. Hilmer SN, Mager DE, Simonsick EM, et al. A drug burden index to define the functional burden of medications in older people. Arch Intern Med 2007; 167 (8): 781-787
14. Cao YJ, Mager DE, Simonsick EM, et al. Physical and cognitive performance and burden of anticholinergics, sedatives, and ACE inhibitors in older women. Clin Pharmacol Ther 2008; 83 (3): 422-429
15. Gnjidic DCR, Le Couteur DG, Abernethy DR, et al. Drug Burden Index and physical function in older Australian men. Br J Clin Pharmacol 2009; 68 (1): 97-105
16. Hilmer SN, Mager DE, Simonsick EM, et al. Drug burden index score and functional decline in older people. Am J Med 2009; 122 (12): 1142-9.e1-2
17. Guralnik JM, Ferrucci L, Simonsick EM, et al. Lowerextremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med 1995; 332 (9): 556-561
18. Gray SL, Penninx BWJH, Blough DK, et al. Benzodiazepine use and physical performance in community-dwelling older women. J Am Geriatr Soc 2003; 51 (11): 1563-1570
19. Mulsant BH, Pollock BG, Kirshner M, et al. Serum anticholinergic activity in a community-based sample of older adults: relationship with cognitive performance. Arch Gen Psychiatry 2003; 60 (2): 198-203
20. Landi F, Russo A, Liperoti R, et al. Anticholinergic drugs and physical function among frail elderly population. Clin Pharmacol Ther 2007; 81 (2): 235-241
21. Tinetti ME. Clinical practice: preventing falls in elderly persons. N Engl J Med 2003; 348 (1): 42-49
22. Tune LE. Anticholinergic effects of medication in elderly patients. J Clin Psychiatry 2001; 62 Suppl. 2: 11-14
23. Iyer S, Naganathan V, McLachlan AJ, et al. Medication withdrawal trials in people aged 65 years and older: a systematic review. Drugs Aging 2008; 25 (12): 1021-1031
24. van der VeldeN, Stricker BHC, Pols HAP, et al. Withdrawal of fall-risk-increasing drugs in older persons: effect on mobility test outcomes. Drugs Aging 2007; 24 (8): 691-699 (Pubitemid 47294716)
25. Hanlon JT, Artz MB, Pieper CF, et al. Inappropriate medication use among frail elderly inpatients. Ann Pharmacother 2004; 389-414
26. Hanlon JT, Schmader KE, Ruby CM, et al. Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc 2001; 49: 200-209
27. Hanlon JT, Lindblad CI, Gray SL. Can clinical pharmacy services have a positive impact on drug-related problems and health outcomes in community-based older adults? Am J Geriatr Pharmacother 2004; 2: 3-13
28. Goulding MR. Inappropriate medication prescribing for elderly ambulatory care patients. Arch Intern Med 2004; 164 (3): 305-312
29. Weekes LM, Mackson JM, Fitzgerald M, et al. National Prescribing Service: creating an implementation arm for national medicines policy. Br J Clin Pharmacol 2005; 59 (1): 112-116
30. Department of Health and Ageing, Australian Government. Medication Management Reviews [online]. Available from URL: http://www.health.gov.au/ internet/main/publishing.nsf/ Content/health-epc-dmmr-answers.htm#6 [Accessed 2009 Jun 17]
31. Nissen D, editor. Mosby's drug consult. St Louis (MO): Mosby Inc., 2004
32. Duplay D, editor. Physicians' desk reference. 58th ed. Montvale (NJ): Thomson PDR, 2004
33. Tallarida RJ. Drug synergism: its detection and applications. J Pharmacol Exp Ther 2001; 298 (3): 865-872
34. World Health Organization. International statistical classification of disease and related health problems. 10th rev. Geneva: World Health Organization, 1992 [online]. Available from URL: http://apps.who.int/ classifications/apps/ icd/icd10online/ [Accessed 2009 Dec 1]
35. WHO Collaborating Centre for Drug Statistics Methodology. ATC classification index with DDDs. Oslo: World Health Organization, 2009 [online]. Available from URL: http://www.whocc.no/atcddd/ [Accessed 2009 Dec 1]
36. Nishtala PS, McLachlan AJ, Hannan PJ, et al. Drug Burden Index in aged care homes: impact of residential medication management reviews. Drugs Aging 2009; 26 (8): 677-686
37. Nishtala PS, McLachlan AJ, Bell JS, et al. Psychotropic prescribing in long-term care facilities: impact of medication reviews and educational interventions. Am J Geriatr Psychiatry 2008; 16 (8): 621-632
38. Pariente A, Dartigues J-F, Benichou J, et al. Benzodiazepines and injurious falls in community dwelling elders. Drugs Aging 2008; 25 (1): 61-70
39. Hanlon JT, Horner RD, Schmader KE, et al. Benzodiazepine use and cognitive function among community-dwelling elderly. Clin Pharmacol Ther 1998; 64 (6): 684-692
40. Pomara N, Deptula D, Medel M, et al. Effects of diazepam on recall memory: relationship to aging, dose, and duration of treatment. Psychopharmacol Bull 1989; 25 (1): 144-148
41. Merchant RA, Li B, Yap KB. Use of drugs with anticholinergic effects and cognitive impairment in community- living older persons. Age Ageing 2008; 38: 105-108
42. Ancelin ML, Artero S, Portet F, et al. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ 2006; 332 (7539): 455-459
43. Bottiggi KA, Salazar JC, Yu L, et al. Long-term cognitive impact of anticholinergic medications in older adults. Am J Geriatr Psychiatry 2006; 14 (11): 980-984
44. Moore AR, O'Keeffe ST. Drug-induced cognitive impairment in the elderly. Drugs Aging 1999; 15 (1): 15-28
45. Fick DM, Mion LC, Beers MH, et al. Health outcomes associated with potentially inappropriate medication use in older adults. Res Nurs Health 2008; 31 (1): 42-51
46. Stuart B, Kamal-Bahl S, Briesacher B, et al. Trends in the prescription of inappropriate drugs for the elderly between 1995 and 1999. Am J Geriatr Pharmacother 2003; 1 (2): 61-74
47. Laroche M-L, Charmes J-P, Merle L. Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clinical Pharmacol 2007; 63 (8): 725-731
48. Fialova D, Topinkova E, Gambassi G, et al. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 2005; 293 (11): 1348-1358 (Pubitemid 40381487)
49. Chin MH, Wang LC, Jin L, et al. Appropriateness of medication selection for older persons in an urban academic emergency department. Acad Emerg Med 1999; 6 (12): 1232-1242
50. Fick DM, Waller JL, Maclean JR, et al. Potentially inappropriate medication use in a Medicare managed care population: association with higher costs and utilization. J Manag Care Pharm 2001; 7 (Sep-Oct): 407-413
51. Hanlon JT, Fillenbaum GG, Kuchibhatla M, et al. Impact of inappropriate drug use on mortality and functional status in representative community dwelling elders. Med Care 2002; 40 (2): 166-176
52. Fillenbaum GG, Hanlon JT, Landerman LR, et al. Impact of inappropriate drug use on health services utilization among representative older community-dwelling residents. Am J Geriatr Pharmacother 2004; 2 (2): 92-101
53. Sorensen L, Stokes JA, Purdie DM, et al. Medication reviews in the community: results of a randomized, controlled effectiveness trial. Br J Clin Pharmacol 2004; 58: 648-664
54. Patel HR, Pruchnicki MC, Hall LE. Assessment for chronic kidney disease service in high-risk patients at community health clinics. Ann Pharmacotherapy 2005; 39 (1): 22-27
55. Krska J, Cromarty JA, Arris F, et al. Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing 2001; 30: 205-211
56. Sellors J, Kaczorowski J, Sellors C, et al. A randomized controlled trial of a pharmacist consultation program for family physicians and their elderly patients. CMAJ 2003; 16: 917-922
57. O'Dell KM, Kucukarslan SN. Impact of the clinical pharmacist on readmission in patients with acute coronary syndrome. Ann Pharmacother 2005; 39 (9): 1423-1427